Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-01

Clinical Trial Update: TMS and Exposure Therapy [NA]

View source ↗

Summary

A terminated clinical trial evaluating transcranial magnetic stimulation (TMS) combined with exposure therapy for arachnophobia and phobia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TMS (Transcranial magnetic stimulation)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Arachnophobia, Phobia | NA | Status: TERMINATED | Results posted: 2021-04-01